Medical diagnosis

Government of Canada Announces Richmond-based 9-8-8 Network partner

Retrieved on: 
Lundi, novembre 20, 2023
CAMH, Mental, Indigenous self-government in Canada, Organization, Volunteering, The Honourable, Government, Medical diagnosis, Mental health, Darkness, Suicide, Housing, DSM-IV codes, Addiction, Statistics, Education, Cryptocurrency, Residential care, Tourism, Chimo, Health

The Government of Canada is taking steps to help ensure that everyone in Canada has access to suicide prevention resources and other crisis supports—whenever and wherever they need them.

Key Points: 
  • The Government of Canada is taking steps to help ensure that everyone in Canada has access to suicide prevention resources and other crisis supports—whenever and wherever they need them.
  • In July, the Government of Canada announced an investment of $156 million over three years to the Centre for Addiction and Mental Health (CAMH) for the implementation and operation of 9-8-8: Suicide Crisis Helpline, building on their experience delivering Talk Suicide Canada.
  • Chief Medical Officer, 9-8-8 and Talk Suicide Canada and Psychiatrist, CAMH
    "Suicide does not discriminate; it affects people of all ages and backgrounds across Canada.
  • If an individual is interested in becoming a responder, they can visit the Talk Suicide Canada website at Volunteer with Talk Suicide Canada or Work with Talk Suicide Canada .

Government of Canada Announces Brampton-based 9-8-8 Network partner

Retrieved on: 
Jeudi, novembre 9, 2023
CAMH, Ministry, Social services, Woman, Mental, Government of Canada, Organization, Volunteering, The Honourable, Health promotion, Government, Medical diagnosis, Mental health, Suicide, Health education, Addiction, Quality of life, Ministry of Health, Cryptocurrency, Nursing, Health

The Government of Canada is taking steps to help ensure that everyone in Canada has access to suicide prevention resources and other crisis supports—whenever and wherever they need them.

Key Points: 
  • The Government of Canada is taking steps to help ensure that everyone in Canada has access to suicide prevention resources and other crisis supports—whenever and wherever they need them.
  • In July, the Government of Canada announced an investment of $156 million over three years to the Centre for Addiction and Mental Health (CAMH) for the implementation and operation of 9-8-8: Suicide Crisis Helpline, building on their experience delivering Talk Suicide Canada.
  • CAMH is the largest mental health teaching hospital in Canada and one of the world's leading research centres in its field.
  • If an individual is interested in becoming a responder, they can visit the Talk Suicide Canada website at Volunteer with Talk Suicide Canada or Work with Talk Suicide Canada .

ECU Health and Acadia Healthcare Host Groundbreaking Ceremony for New Behavioral Health Hospital

Retrieved on: 
Mercredi, novembre 1, 2023
Mental Health, Health, Infectious Diseases, Hospitals, Physical Therapy, Other Health, Managed Care, Post-traumatic stress disorder, Science, Child, Jimmy Simpson (North Carolinian racing driver), Adolescence, Nursing, Hope, Psychiatry, Bipolar disorder, Organization, Mental health, Multimedia, ECU Health Medical Center, PTSD, Environment, Medicine, ECU Health, Medical diagnosis, Student, Partnership, Hospital, East Carolina University, William R. Brody, North Carolina Department of Health and Human Services, ECU, Acadia Healthcare, Social work, ECU Brody School of Medicine, Depression, Anxiety, Patient, Bed

ECU Health and Acadia Healthcare held a ceremony today to celebrate the start of construction on its previously announced state-of-the-art, 144-bed behavioral health hospital in Greenville, North Carolina.

Key Points: 
  • ECU Health and Acadia Healthcare held a ceremony today to celebrate the start of construction on its previously announced state-of-the-art, 144-bed behavioral health hospital in Greenville, North Carolina.
  • View the full release here: https://www.businesswire.com/news/home/20231101651362/en/
    ECU Health and Acadia Healthcare Break Ground on Construction of a New Behavioral Health Hospital in Greenville, North Carolina, with an anticipated opening in Spring 2025.
  • “We are pleased construction is underway for our new behavioral health hospital, and this moment marks another milestone in our effort to improve access to behavioral health care for the region.
  • It will be a beacon of hope for patients and families in eastern North Carolina.”
    To learn more about the partnership between ECU Health and Acadia Healthcare, visit ENCBehavioralHealth.org .

Lynn Mason Appointed Chief Executive Officer for IVI RMA America

Retrieved on: 
Mercredi, novembre 1, 2023
Biotechnology, Other Health, Health, Pharmaceutical, Health Technology, Fertility, Woman, Disability studies, RMA, Washington University in St. Louis, Service, Physician, BSBA, 1998 Harvard vs. Stanford women's basketball game, MBA, Multimedia, DaVita Inc., American Heart, Growth, IVI, Shoe, Medical diagnosis, Business, Association of Latino Professionals in Finance and Accounting, Mason, Chenming Hu, Culture, Reproductive medicine, Patient, Gloucestershire Care Services NHS Trust, DSM-IV codes, Accounting, Management

IVI RMA America, the North American business of IVI RMA, the largest reproductive medicine group in the world, today announced the appointment of Lynn Mason as Chief Executive Officer.

Key Points: 
  • IVI RMA America, the North American business of IVI RMA, the largest reproductive medicine group in the world, today announced the appointment of Lynn Mason as Chief Executive Officer.
  • Mason currently serves on the Boards of Directors of nonprofits Shoes-That-Fit and the American Heart Association-Go Red for Women.
  • “IVI RMA has a stellar reputation for the industry’s best outcomes, most innovative R&D platform, and sharpest talent, and I am thrilled and honored to join as CEO for America,” said Mason.
  • “I’m eager to support our physician leaders in expanding our presence and strengthening our culture to make IVI RMA America the natural first choice for patients, physicians, and medical partners.”
    “The team and I look forward to Lynn bringing a fresh and energized perspective to our business and complementing our scientific leaders,” added Thomas A. Molinaro, M.D., Medical Director, IVI RMA America.

Iterative Health Presents Award-Winning Research on the Benefits of Gastroenterological Technology at the American College of Gastroenterology Annual Scientific Meeting

Retrieved on: 
Lundi, octobre 23, 2023
Technology, Surgery, Medical Devices, Medical Supplies, Clinical Trials, Other Health, Health, General Health, Artificial Intelligence, GI, FDA, Intelligence, American College, Harvard Medical School, Crohn's disease, MPH, Outline of health sciences, Adenoma, Use, ACG, Prevalence, Rutgers University–New Brunswick, Cade, Publication, Doctor of Philosophy, MBA, American College of Gastroenterology, Research, Computer science, Computer-aided, George Washington University School of Medicine & Health Sciences, Artificial intelligence, APC, Colonoscopy, School, University of North Dakota, CRC, Clinical trial, Abstract, University, Medical diagnosis, Mount Auburn Hospital, Safety, Boston Medical Center, Inflammatory bowel disease, MS, Medical imaging, Management, Medical device, Gastroenterology, MD, Colitis, Geriatrics, Medicine

Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, announced today the results of new research unveiled at the American College of Gastroenterology (ACG) Annual Scientific Meeting.

Key Points: 
  • Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, announced today the results of new research unveiled at the American College of Gastroenterology (ACG) Annual Scientific Meeting.
  • This research represents strides toward enhancing the detection of precursor adenomas and streamlining clinical trial recruitment processes in gastroenterology, ultimately bringing us closer to a future of advancing patient care in the field.
  • The publications include:
    Authors: William Holderman, MD; Parth Jain; Mitchell Reddan, MS; Haig Soghigian, MBA; Christopher Fourment, MD.
  • To learn more about Iterative Health, please visit iterative.health .

Artificial Intelligence (AI) in Medical Diagnostics Market Worth $3.7 billion | MarketsandMarkets

Retrieved on: 
Jeudi, octobre 19, 2023
Cloud, Research, MRI, Health status of Asian Americans, Roger Hawkins (drummer), Medical diagnosis, Drug discovery, Ohio State University, Nvidia, Physician, Microsoft, Siemens Healthineers, Personalized medicine, Xeon, Disease, Remote diagnostics, Health, Google Cloud, AMD, Artificial intelligence, Scalability, Aging Research and Drug Discovery, GE, Intel, Telehealth, CT, GE HealthCare, HBM, Pandemic, AI, Enhanced Imaging System, Diagnosis, Patient, Data analysis, Mayo Clinic, Workload, Medical device, Nursing, Medical imaging, Sapphire Rapids

In October 2022, Google Cloud (US) launched Medical Imaging Suite, a new industry solution that makes imaging healthcare data more accessible, interoperable, and useful.

Key Points: 
  • In October 2022, Google Cloud (US) launched Medical Imaging Suite, a new industry solution that makes imaging healthcare data more accessible, interoperable, and useful.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=22519734
    Artificial Intelligence (AI) in Medical Diagnostics Market Advantages:
    Improved Accuracy: AI systems can analyze vast amounts of medical data with precision, reducing the likelihood of human errors in diagnosis and increasing the accuracy of results.
  • Remote Diagnostics: AI enables remote diagnostics and telemedicine, improving access to healthcare in remote or underserved areas, and during global health crises like pandemics.
  • These advantages highlight the transformative potential of AI in the medical diagnostics market, improving patient care, increasing efficiency, and advancing the capabilities of healthcare professionals.

Artificial Intelligence (AI) in Medical Diagnostics Market Worth $3.7 billion | MarketsandMarkets

Retrieved on: 
Jeudi, octobre 19, 2023
Cloud, Research, MRI, Health status of Asian Americans, Roger Hawkins (drummer), Medical diagnosis, Drug discovery, Ohio State University, Nvidia, Physician, Microsoft, Siemens Healthineers, Personalized medicine, Xeon, Disease, Remote diagnostics, Health, Google Cloud, AMD, Artificial intelligence, Scalability, Aging Research and Drug Discovery, GE, Intel, Telehealth, CT, GE HealthCare, HBM, Pandemic, AI, Enhanced Imaging System, Diagnosis, Patient, Data analysis, Mayo Clinic, Workload, Medical device, Nursing, Medical imaging, Sapphire Rapids

In October 2022, Google Cloud (US) launched Medical Imaging Suite, a new industry solution that makes imaging healthcare data more accessible, interoperable, and useful.

Key Points: 
  • In October 2022, Google Cloud (US) launched Medical Imaging Suite, a new industry solution that makes imaging healthcare data more accessible, interoperable, and useful.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=22519734
    Artificial Intelligence (AI) in Medical Diagnostics Market Advantages:
    Improved Accuracy: AI systems can analyze vast amounts of medical data with precision, reducing the likelihood of human errors in diagnosis and increasing the accuracy of results.
  • Remote Diagnostics: AI enables remote diagnostics and telemedicine, improving access to healthcare in remote or underserved areas, and during global health crises like pandemics.
  • These advantages highlight the transformative potential of AI in the medical diagnostics market, improving patient care, increasing efficiency, and advancing the capabilities of healthcare professionals.

 Seres Therapeutics to Highlight VOWST™ Data at IDWeek

Retrieved on: 
Jeudi, octobre 12, 2023
Biotechnology, General Health, Pharmaceutical, Health, Food, Abstract, Medical diagnosis, CDI, Risk, Clostridioides difficile infection, US Foods, FDA, Therapy, Doctor of Philosophy, Variometer, Post hoc, Recurrence, Infection, David Berry (inventor), Patient, Pharmaceutical industry, Communications satellite

“The data we are presenting this year at IDWeek build upon our earlier findings that the gastrointestinal microbiome is similarly disrupted in patients with first or multiple rCDI.

Key Points: 
  • “The data we are presenting this year at IDWeek build upon our earlier findings that the gastrointestinal microbiome is similarly disrupted in patients with first or multiple rCDI.
  • The introduction of VOWST has provided a means to alleviate suffering and health risks associated with recurrent instances of this serious disease," said Matthew Henn, Ph.D., Chief Scientific Officer at Seres.
  • Report any infection that is suspected to have been transmitted by VOWST to Aimmune Therapeutics, Inc. at 1-833-246-2566.
  • To report SUSPECTED ADVERSE REACTIONS, contact Aimmune Therapeutics at 1-833-AIM-2KNO (1-833-246-2566), or the FDA at 1-800-FDA-1088, or visit www.fda.gov/MedWatch .

The Hyperspectral Imaging System Market Is Set To Reach $41 Billion By 2027, With Rising Demand From The Automotive Sector - By The Business Research Company

Retrieved on: 
Jeudi, septembre 28, 2023
Corning Inc., Insurance Institute for Highway Safety, Insurance, Hyperspectral imaging, Medical diagnosis, Growth, AVS, NIR, Medical imaging

LONDON, Sept. 28, 2023 /PRNewswire/ -- The global hyperspectral imaging system market is on a trajectory of remarkable expansion, driven by the growing demand for advanced imaging technology, particularly in the autonomous vehicle sector. According to the latest Hyperspectral Imaging Systems Global Market Report 2023 from The Business Research Company, the market is set to achieve a remarkable growth rate in 2023 and beyond, with the global hyperspectral imaging system market size projected to reach $21.13 billion in 2023, marking a notable CAGR of 18.0%. Furthermore, this growth is expected to continue, propelling the market to an impressive $41.96 billion by 2027, with an anticipated CAGR of 18.7%.

Key Points: 
  • According to the latest Hyperspectral Imaging Systems Global Market Report 2023 from The Business Research Company, the market is set to achieve a remarkable growth rate in 2023 and beyond, with the global hyperspectral imaging system market size projected to reach $21.13 billion in 2023, marking a notable CAGR of 18.0%.
  • One of the key catalysts for the growth of the hyperspectral imaging system market is the surge in autonomous vehicles (AVs).
  • The global hyperspectral imaging system market is characterized by its high fragmentation, with a multitude of players vying for market share.
  • In 2022, Asia Pacific emerged as the largest region in the hyperspectral imaging systems market , accounting for 19.6% of the global market share.

The Hyperspectral Imaging System Market Is Set To Reach $41 Billion By 2027, With Rising Demand From The Automotive Sector - By The Business Research Company

Retrieved on: 
Jeudi, septembre 28, 2023
Corning Inc., Insurance Institute for Highway Safety, Insurance, Hyperspectral imaging, Medical diagnosis, Growth, AVS, NIR, Medical imaging

LONDON, Sept. 28, 2023 /PRNewswire/ -- The global hyperspectral imaging system market is on a trajectory of remarkable expansion, driven by the growing demand for advanced imaging technology, particularly in the autonomous vehicle sector. According to the latest Hyperspectral Imaging Systems Global Market Report 2023 from The Business Research Company, the market is set to achieve a remarkable growth rate in 2023 and beyond, with the global hyperspectral imaging system market size projected to reach $21.13 billion in 2023, marking a notable CAGR of 18.0%. Furthermore, this growth is expected to continue, propelling the market to an impressive $41.96 billion by 2027, with an anticipated CAGR of 18.7%.

Key Points: 
  • According to the latest Hyperspectral Imaging Systems Global Market Report 2023 from The Business Research Company, the market is set to achieve a remarkable growth rate in 2023 and beyond, with the global hyperspectral imaging system market size projected to reach $21.13 billion in 2023, marking a notable CAGR of 18.0%.
  • One of the key catalysts for the growth of the hyperspectral imaging system market is the surge in autonomous vehicles (AVs).
  • The global hyperspectral imaging system market is characterized by its high fragmentation, with a multitude of players vying for market share.
  • In 2022, Asia Pacific emerged as the largest region in the hyperspectral imaging systems market , accounting for 19.6% of the global market share.